Market Exclusive

Analyst Activity – Needham & Company LLC Initiates Coverage On Diplomat Pharmacy (NYSE:DPLO) With a Buy

Analyst Ratings For Diplomat Pharmacy (NYSE:DPLO)

Today, Needham & Company LLC initiated coverage on Diplomat Pharmacy (NYSE:DPLO) with a Buy with a price target of $19.75.

There are 1 sell rating, 8 hold ratings, 2 buy ratings on the stock.

The current consensus rating on Diplomat Pharmacy (NYSE:DPLO) is Hold (Score: 2.09) with a consensus target price of $17.89 per share, a potential 14.48% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Diplomat Pharmacy (NYSE:DPLO)
Diplomat Pharmacy (NYSE:DPLO) has insider ownership of 35.40% and institutional ownership of 72.55%.

Recent Trading Activity for Diplomat Pharmacy (NYSE:DPLO)
Shares of Diplomat Pharmacy closed the previous trading session at 15.63 up +0.07 0.45% with 304,671 shares trading hands.

Exit mobile version